-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Achieve Life Sciences with Market Outperform Rating, Announces Price Target of $19

Benzinga·11/25/2025 13:41:39
Listen to the news
Citizens analyst Jason N. Butler initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Market Outperform rating and announces Price Target of $19.